|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 24/14/24 | PERNOD RICARD : looks for more bolt-on deals after U.S. buy | RE |
| 23/14/23 | Allergan : Activist investors see Ackman-Valeant deal as a model to follow | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Greg Hughes
CEO | Chief Executive Officer | - | 01/10/2023 |
Gina Rossi
DFI | Director of Finance/CFO | 54 | 01/04/2017 |
John Rosair
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/01/2015 | |
Haruhisa Inada
BRD | Director/Board Member | - | 30/04/2014 |
Shingo Torii
BRD | Director/Board Member | 73 | 01/05/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.77% | -1.22% | -1.47% | -19.05% | 27TCr | ||
| +0.83% | +3.06% | +9.00% | -30.62% | 5.65TCr | ||
| +1.03% | -2.60% | -38.96% | -53.34% | 4.27TCr | ||
| +3.40% | -2.08% | -34.25% | -46.70% | 2.36TCr | ||
| +0.66% | +2.81% | -9.96% | -56.01% | 2.02TCr | ||
| +3.73% | -1.93% | -42.99% | -62.44% | 1.76TCr | ||
| +2.03% | +0.23% | +9.97% | -48.24% | 1.42TCr | ||
| +2.06% | +0.95% | +0.77% | +38.95% | 1.07TCr | ||
| +0.56% | +2.08% | +21.64% | -33.13% | 902.63Cr | ||
| Average | +1.79% | +0.33% | -9.58% | -34.51% | 5TCr | |
| Weighted average by Cap. | +1.69% | -0.22% | -6.40% | -28.12% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















